What should you know about an MGUS test?

MGUS stands for monoclonal gammopathy of undetermined significance. Blood or urine testing may find an antibody-like protein made by a group of plasma cells. The finding is not the same as multiple myeloma, and it may cause no symptoms. A clinician may compare protein levels with blood counts, kidney tests, calcium results, and sometimes imaging or a bone marrow test to understand the finding.

The result is interpreted with your health history and other test results. A repeat test can show whether the protein remains stable. Monitoring is used because, in some people, MGUS can change over time; the timing depends on the pattern of results and your clinician’s assessment.

Keep a record of the test name, result, and recommended review date. Ask whether the sample was blood, urine, or both, and which additional results shaped the plan. Attend arranged follow-up even when you feel well. Bring a list of medicines and mention new bone pain, unusual tiredness, repeated infections, numbness, or changes in urination.

If your clinician refers you to a haematology team, that visit can clarify whether further testing is useful. Learn more about [Multiple Myeloma](/conditions/multiple-myeloma/) and [Follow-Up After Cancer Treatment](/treatments/survivorship-and-rehabilitation/post-treatment-surveillance/) if either topic is part of your discussion.

Contact your healthcare team promptly for new or worsening bone pain, marked weakness, repeated infections, unexpected bruising, or reduced urine. Seek urgent care for severe pain, confusion, trouble breathing, or inability to pass urine. These symptoms have several possible causes, so they do not by themselves diagnose a blood cancer; they do warrant assessment.

Ask: What protein was found, and what does its pattern mean? Which blood or urine tests should be repeated? Do I need imaging or a specialist review? What symptoms should prompt an earlier call? When is my next appointment?